Drug treatment for lower urinary tract symptoms in women with voiding dysfunction

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 8, 2014, Pages

  Yi, Zhan Miao ^a   Zhao, Rong Sheng ^a   Zhai, Suo Di ^a   Wang, Guo Liang ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; MUSCARINIC AGENT;

ARTICLE; BLADDER EMPTYING; DRUG EFFICACY; DRUG SAFETY; HUMAN; LOWER URINARY TRACT SYMPTOM; MICTURITION DISORDER; PATIENT SATISFACTION; POSTVOID RESIDUAL URINE VOLUME; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TREATMENT OUTCOME; WOMEN'S HEALTH;

EID: 85041840031     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD011264     Document Type: Article

References (24)

1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al.The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 2003;61(1):37-49.
2. Barendrecht MM, Oelke M, Laguna MP, Michel MC. Is the use of parasympathomimetics for treating an underactive urinary bladder evidence-based?. BJU International 2007;99(4):749-52.
3. Chapple C, Abrams P. Male Lower Urinary Tract Symptoms (LUTS). An international consultation on male LUTS. International Consultation on Urological Dieases, 2012.
4. Choi YS, Kim JC, Lee KS, Seo JT, Kim HJ, Yoo TK, et al.Analysis of female voiding dysfunction: a prospective, multi-center study. International Urology and Nephrology 2013;45(4):989-94.
5. Cody JD, Nabi G, Dublin N, McClinton S, Neal DE, Pickard R, et al.Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy. Cochrane Database of Systematic Reviews 2012, Issue 2. [DOI: 10.1002/14651858.CD003306.pub2]
6. Hagen S, Stark D. Conservative prevention and management of pelvic organ prolapse in women. Cochrane Database of Systematic Reviews 2011, Issue 12. [DOI: 10.1002/14651858.CD003882.pub4]
7. Hajebrahimi S, Taleschian Tabrizi N, Sadeghi-Bazargani H, Sadeghi Ghyassi F, Farhadi F. Non-drug treatment for lower urinary tract symptoms in women with voiding dysfunction. Cochrane Database of Systematic Reviews (In progress).
8. Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al.An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. International Urogynecology Journal 2010;21(1):5-26.
9. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
10. Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, et al.Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. European Urology 2006;50(6):1306-14.
11. Jackson MJ, Veeratterapillay R, Harding C, Dorkin T. Intermittent self-dilatation for urethral stricture disease in men. Cochrane Database of Systematic Reviews 2012, Issue 12. [DOI: 10.1002/14651858.CD010258]
12. Kodner CM, Thomas Gupton EK. Recurrent urinary tract infections in women: diagnosis and management. American Family Physician 2010;82(6):638-43.
13. van Koeveringe GA, Vahabi B, Andersson KE, Kirschner-Herrmans R, Oelke M. Detrusor underactivity: a plea for new approaches to a common bladder dysfunction. Neurourology and Urodynamics 2011;30(5):723-8.
14. Maher C, Feiner B, Baessler K, Schmid C. Surgical management of pelvic organ prolapse in women. Cochrane Database of Systematic Reviews 2013, Issue 4. [DOI: 10.1002/14651858.CD004014.pub5]
15. Meyer LE, Brown JN. Tamsulosin for voiding dysfunction in women. International Urology and Nephrology 2012;44(6):1649-56.
16. Neal DE Jr. Complicated urinary tract infections. Urologic Clinics of North America 2008;35(1):13-22.
17. Raheem AA, Madersbacher H. Voiding dysfunction in women: How to manage it correctly. Arab Journal of Urology 2013;11(3):194-202.
18. The Thomson Corporation. Reference Manager Professional Edition. 12. New York: The Thomson Corporation, 2012.
19. The Nordic Cochrane Centre. The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre. The Cochrane Collaboration, 2014.
20. Robinson D, Staskin D, Laterza RM, Koelbl H. Defining female voiding dysfunction: ICI-RS 2011. Neurourology and Urodynamics 2012;31(3):313-6.
21. Torre M, Guida E, Bisio G, Scarsi P, Piatelli G, Cama A, et al.Risk factors for renal function impairment in a series of 502 patients born with spinal dysraphisms. Journal of Pediatric Urology 2011;7(1):39-43.
22. Utomo E, Blok B. Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction. Cochrane Database of Systematic Reviews 2011, Issue 10. [DOI: 10.1002/14651858.CD004927.pub3]
23. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30(6):473-83.
24. Wong SSW, Aboumarzouk OM, Narahari R, O'Riordan A, Pickard R. Simple urethral dilatation, endoscopic urethrotomy, and urethroplasty for urethral stricture disease in adult men. Cochrane Database of Systematic Reviews 2012, Issue 12. [DOI: 10.1002/14651858.CD006934.pub3]